Interim results from the global MATTERHORN study mark the first time an immunotherapy has demonstrated statistically ...

Here's the complete Xbox roundup from the MIX Summer Showcase 2025: NYC 2055: a city beyond salvation. Blast your way through this dense cyberpunk jungle in NEON INFERNO, an explosive fusion of 2D run ...

Save a town from a mysterious plague in this in narrative first-person RPG. Learn the stories of its unusual inhabitants. Shape their lives with your decrees. Diagnose patients. Face the Plague.

Moscow-based developer Ice-Pick Lodge has provided players with an in-depth glimpse at its upcoming RPG, Pathologic 3, via a ...

The primary end point, major pathologic response (MPR), was reviewed per consensus criteria and centrally confirmed: In the monotherapy arm, the MPR rate was 33.3%, with all responses being pathologic ...

CHICAGO -- Neoadjuvant osimertinib (Tagrisso) with or without chemotherapy significantly increased major pathologic response ...

Check out the time-manipulation gameplay mechanic in this new Pathologic 3 trailer for the upcoming adventure RPG. Save a town from a mysterious plague in Pathologic 3. Learn the stories of its ...

A more recent prostatectomy was associated with lower likelihood of pGG1 prostatectomy in two cohorts. HealthDay News — Since 2010, there has been a decrease in the proportion of prostatectomies that ...

HER2+ breast cancer usually undergo pre-operative therapy with multi-agent chemotherapy in combination with anti-HER2 antibodies, followed by surgery.

HER2+ breast cancer usually undergo preoperative therapy with multi-agent chemotherapy in combination with anti-HER2 ...

Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, announced the presentation of new clinical results from the PREDICT DNA and SCANDARE studies highlighting the ...

Daiichi Sankyo Company Limited (OTC:DSNKY) and AstraZeneca (NASDAQ:AZN) announced promising results from 3 clinical trials: ...